Medical device recalls Moderate risk

Siemens Healthcare Diagnostics, Inc recalls Siemens Atellica IM aTG (100 test kit) Siemens Material Number (SMN): 10995461

Recall date
December 7, 2018
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-1235-2019
FDA classification
Class II
Brand / firm
Siemens Healthcare Diagnostics, Inc
Sold / distributed
Nationwide Foreign: Belgium¿¿¿¿¿¿¿¿ Croatia¿¿¿¿¿¿¿¿ Czech¿Republic¿ Denmark¿¿¿¿¿¿¿¿ France¿¿¿¿¿¿¿¿¿ Germany¿¿¿¿¿¿¿¿ Greece¿¿¿¿¿¿¿¿¿ Ireland¿¿¿¿¿¿¿¿ Italy¿¿¿¿¿¿¿¿¿¿ Poland¿¿¿¿¿¿¿¿¿ Portugal¿¿¿¿¿¿¿ Slovakia¿¿¿¿¿¿¿ Spain¿¿¿¿¿¿¿¿¿¿ Switzerland¿¿¿¿ Turkey¿¿¿¿¿¿¿ BOGOTA QUARRY BAY, HONG KONG YANGON SANTI…

Why it was recalled

Positive bias anti-thyroglobulin with ADVIA Centaur aTG kit lots ending in 316 and lower and Atellica IM aTG kit lots ending in 317 and lower when compared to the standardization to World Health Organization (WHO) Reference Preparation MRC 65/93 stated in the Instructions for Use (IFU).

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Siemens Atellica IM aTG (100 test kit) Siemens Material Number (SMN): 10995461

Get recall alerts

Free email alert whenever Siemens Healthcare Diagnostics, Inc has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Siemens Healthcare Diagnostics, Inc